𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Connective tissue growth factor (CTGF) transactivates nuclear factor of activated T-cells (NFAT) in cells of the osteoblastic lineage

✍ Scribed by Anna Smerdel-Ramoya; Stefano Zanotti; Ernesto Canalis


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
196 KB
Volume
110
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Connective tissue growth factor (CTGF), a member of the Cyr 61, CTGF, Nov (CCN) family of proteins, regulates multiple cellular functions. Overexpression of CTGF in vivo causes osteopenia, but in vitro CTGF can induce osteoblastogenesis. To investigate mechanisms involved in the effects of CTGF on osteoblastic cell differentiation, we examined whether CTGF modifies the activity of nuclear factor of activated T‐cells (NFATc) 1, a transcription factor that cooperates with osterix in the formation of new bone. CTGF increased the transactivation of a transiently transfected reporter construct, where 9 NFAT binding sites direct the expression of luciferase (9xNFAT‐Luc) and the activity of the Regulators of calcineurin 1 exon 4 (Rcan1.4) promoter, an NFAT target gene. We postulated that CTGF could modify the phosphorylation of NFAT by regulating glycogen synthase kinase 3β (GSK3β). CTGF increased the mRNA levels of Protein kinase cyclic guanosine monophosphate (cGMP) dependent type II (Prkg2), the gene encoding for cGMP dependent protein kinase II (cGKII) which phosphorylates GSK3β. Accordingly, CTGF induced GSK3β phosphorylation and decreased the active pool of GSK3β, a kinase that phosphorylates NFAT and leads to its nuclear export. As a consequence, CTGF favored the nuclear localization of NFATc1. Downregulation of PRKG2 by RNA interference reversed the effect of CTGF on the transactivation of the 9xNFAT reporter construct and the Rcan 1.4 promoter, confirming the role of cGKII in the activation of NFAT by CTGF. In conclusion, CTGF enhances NFAT signaling through the induction of cGKII and the phosphorylation of GSK3β. J. Cell. Biochem. 110: 477–483, 2010. © 2010 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


NUCLEAR FACTOR OF ACTIVATED T CELLS (NFA
✍ MARTA WISNIEWSKA; MAGDALENA STANCZYK; BARBARA GRZELAKOWSKA-SZTABERT; BOZENA KAMI 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 402 KB

Cell death plays a critical role in the generation of an effective immune system. During maturation T lymphocytes are generated, censored and eliminated in the thymus. These events are temporally associated with developmental changes in the levels of transcription factors including NFAT. The NFAT tr

Hyaluronic acid modulates gene expressio
✍ Yu-Tsang Lee; Hung-Jen Shao; Jyh-Horng Wang; Haw-Chang Liu; Sheng-Mou Hou; Tai-H 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Intraarticular injection of hyaluronan (hyaluronic acid; HA) is the common way to treat osteoarthritis (OA) of knees. This treatment cannot only maintain the viscoelastic properties of knee but also release the OA pain. However, the exact molecular mechanism is unknown. In this study, after human sy

Calcineurin/nuclear factor of activated
✍ Vbenosawemwinghaye Orhue; Arihiko Kanaji; Marco S. Caicedo; Amarjit S. Virdi; Da 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 239 KB

## Abstract Aseptic loosening is the devastating long term complication of total hip arthroplasty and orthopedic implant debris has been shown to trigger an intense inflammatory reaction leading to resorption of the bone matrix. Inflammatory cytokines, such as tumor necrosis factor‐α (TNFα), have b

Immunomonitoring of nuclear factor of ac
✍ Alexandra Zahn; Nadja Schott; Ulf Hinz; Wolfgang Stremmel; Jan Schmidt; Tom Gant 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

Long-term calcineurin inhibitor (CNI) treatment can cause serious side effects in liver allograft recipients. An optimal risk-tobenefit ratio for CNI blood levels has not been established. Pharmacodynamic drug monitoring through the measurement of the CNI biological activity, that is, the expression